Sub Heading

Clinical Trials Details

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer (STRIKE)

IRB Protocol Number
A032201

Clinical Trial Categories

  • Kidney Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men and women 18+ years old, with a diagnosis of renal cell carcinoma with clear cell component following a radical or partial nephrectomy, and no prior systemic treatment.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.